For research use only. Not for therapeutic Use.
LCZ696 Sodium Salt Hydrate(CAT: C000243) is a pharmaceutical compound with a unique mechanism of action. It is a combination drug that consists of two active ingredients: sacubitril and valsartan. Sacubitril acts as a neprilysin inhibitor, increasing the levels of beneficial peptides, while valsartan is an angiotensin receptor blocker that dilates blood vessels and reduces blood pressure.
CAS Number | 1884447-69-1 |
Synonyms | N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine, compound with a-Ethyl (aR,gS)-g-[(3-carboxy-1-oxopropyl)amino]-a-methyl[1,1′-biphenyl]-4-pentanoate, Sodium Salt, Hydrate; Entresto; Sacubitril-valsartan; Sacubitril-valsartan Mixture |
Molecular Formula | C₂₄H₂₇N₅Na₂O₃ • C ₂₄H₂₈NNaO₅ •xH₂O |
Purity | ≥95% |
Solubility | DMSO (Slightly), Methanol (Sparingly) |
Appearance | White to Off-White Solid |
Storage | 4°C |
Reference | Ruilope, L.M.; et al.: Lancet, 375, 1255 (2010) |